SCHEMBL31578362

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)N[C@@H](Cc1cnc[nH]1)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.73

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	9/20	0.73

▸	CCKBR	P32239	1/20	0.73

▸	PTH1R	Q03431	9/20	0.69

▸	ECE1	P42892	1/20	0.69

▸	MUS81	Q96NY9	1/20	0.69

▸	NR3C1	P04150	2/20	0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Oxyntomodulin SCHEMBL29349603	0.90	GLP1R (0.84)	GLP1RCCKBRPTH1RECE1MUS81
SCHEMBL29492081	0.90	GLP1R (0.71)	GLP1RCCKBRECE1MUS81NR3C1
Teduglutide SCHEMBL29373256	0.89	GLP1R (0.82)	GLP1RCCKBRPTH1RECE1MUS81
Teduglutide SCHEMBL20898050	0.89	GLP1R (0.82)	GLP1RCCKBRPTH1RECE1MUS81
SCHEMBL29376455	0.89	PTH1R (0.81)	GLP1RCCKBRPTH1RECE1MUS81
Dermaseptin S1 SCHEMBL30063560	0.89	PTH1R (0.68)	GLP1RCCKBRPTH1RECE1MUS81
SCHEMBL29373391	0.89	GLP1R (0.72)	GLP1RCCKBRECE1MUS81NR3C1
SCHEMBL29354319	0.89	GLP1R (0.81)	GLP1RCCKBRPTH1RECE1MUS81
SCHEMBL15268863	0.89	GLP1R (0.81)	GLP1RCCKBRPTH1RECE1MUS81
SCHEMBL29694495	0.89	PTH1R (0.78)	GLP1RCCKBRPTH1RECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025245160-A1	MYOSTATIN-SELECTIVE INHIBITORS FOR TREATING METABOLIC DISORDERS	SCHOLAR ROCK, INC. (US)	2025-11-27	—	—	WO	disclosed
US-20250163168-A1	NOVEL ANTIBODIES AND ANTIBODY CONJUGATES FOR THE TREATMENT OF METABOLIC DISORDERS	PFIZER INC. (US)	2025-05-22	—	—	US	disclosed